Article Versions Notes

Saeed MEM, Yücer R, Dawood M, Hegazy M-EF, Drif A, Ooko E, Kadioglu O, Seo E-J, Kamounah FS, Titinchi SJ, et al. In Silico and In Vitro Screening of 50 Curcumin Compounds as EGFR and NF-κB Inhibitors. International Journal of Molecular Sciences. 2022; 23(7):3966. https://doi.org/10.3390/ijms23073966

Saeed, Mohamed E. M., Rümeysa Yücer, Mona Dawood, Mohamed-Elamir F. Hegazy, Assia Drif, Edna Ooko, Onat Kadioglu, Ean-Jeong Seo, Fadhil S. Kamounah, Salam J. Titinchi, and et al. 2022. "In Silico and In Vitro Screening of 50 Curcumin Compounds as EGFR and NF-κB Inhibitors" International Journal of Molecular Sciences 23, no. 7: 3966. https://doi.org/10.3390/ijms23073966

Saeed, M. E. M., Yücer, R., Dawood, M., Hegazy, M.-E. F., Drif, A., Ooko, E., Kadioglu, O., Seo, E.-J., Kamounah, F. S., Titinchi, S. J., Bachmeier, B., & Efferth, T. (2022). In Silico and In Vitro Screening of 50 Curcumin Compounds as EGFR and NF-κB Inhibitors. International Journal of Molecular Sciences, 23(7), 3966. https://doi.org/10.3390/ijms23073966